Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs Intrathecal Dexamethasone for PDPH Prevention
NCT04709029Unknown
- Sponsor
- Ain Shams University
- Start
- Jan 2021
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in post-dural puncture headache (PDPH) (2 arms), sponsored by Ain Shams University. Primary endpoint: Prevention of postdural puncture headache at 48 hours. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT04709029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709029.